CUTANEOUS T-CELL LYMPHOMA STAGE I

CUTANEOUS T-CELL LYMPHOMA STAGE I was reported 36 times

CUTANEOUS T-CELL LYMPHOMA STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEXAROTENE 9 0.0068
1 RASBURICASE 9 0.0036
2 VANCOMYCIN HYDROCHLORIDE 9 0.0011
3 PIPERACILLIN SODIUM,TAZOBACTAM SODIUM 9 0.0003
4 PIPERACILLIN AND TAZOBACTAM 4 0.0003
5 MEROPENEM 9 0.0003
6 FILGRASTIM 9 0.0002
7 PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM 4 0.0002
8 FINGOLIMOD HYDROCHLORIDE 1 0.0002
9 GOLIMUMAB 2 0.0002
10 VANCOMYCIN 9 0.0002
11 CALCIUM CARBONATE 9 0.0001
12 ADALIMUMAB-FKJP 6 0.0001
13 ADALIMUMAB-AATY 6 0.0001
14 ADALIMUMAB-ADAZ 6 0.0001
15 BRENTUXIMAB VEDOTIN 1 0.0001
16 HYDROXYUREA 2 0.0001
17 CLOBETASOL PROPIONATE OINTMENT USP, 0.05% 1 0.0001
18 CLOBETASOL PROPIONATE 1 0.0001
19 ALLOPURINOL 9 0.0001
20 CYCLOSPORINE 6 0.0001
21 OFATUMUMAB 1 0.0000
22 USTEKINUMAB 3 0.0000
23 FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE 1 0.0000
24 DUPILUMAB 12 0.0000
25 FUROSEMIDE 9 0.0000
26 PREDNISOLONE ORAL SOLUTION 4 0.0000
27 METHOTREXATE SODIUM 9 0.0000
28 MORPHINE SULFATE 2 0.0000
29 FINGOLIMOD HCL 1 0.0000
30 ADALIMUMAB 6 0.0000
31 TACROLIMUS OINTMENT 0.1% 1 0.0000
32 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
33 AMLODIPINE BESYLATE 1 0.0000
34 TACROLIMUS 1 0.0000
35 SECUKINUMAB 1 0.0000
36 IBUPFROFEN 1 0.0000
37 IBUPROFEN TABLETS USP, 200MG 1 0.0000
38 IBUPROFEN ORAL 1 0.0000
39 IBUPROFEN CAPSULES 200 MG 1 0.0000
40 IBUPROFEN 1 0.0000
41 ALBUTEROL SULFATE 1 0.0000
42 GABAPENTIN 1 0.0000
43 ASPIRIN 1 0.0000